BioPharma Dive July 24, 2024
The presumptive Democratic nominee has a history of taking on pharma over drug prices and supporting women’s healthcare access.
Vice President Kamala Harris is likely on her way to becoming the Democratic presidential nominee now that President Joe Biden is dropping out of the race. Harris has already won endorsements from the president and many political leaders in her party, and her campaign swept in a record-breaking $81 million in donations during a 24-hour period this week.
If she prevails in November, what would a Kamala Harris administration mean for pharma? Her record, public comments and career follow a familiar trajectory as many Democratic lawmakers.
Harris has shown support for drug pricing reform and took a hard line in several...
Today's Sponsors
Today's Sponsor